Lili Mi

机构：Hebei Medical University, Fourth Hospital of Hebei Medical University, Hohhot First Hospital

发表论文 36 篇 · 总被引 333 次 · h-index 11

代表论文

• Sarcopenia and Systemic Inflammation Response Index Predict Response to Systemic Therapy for Hepatocellular Carcinoma and Are Associated With Immune Cells (2022 · Frontiers in Oncology · 被引 59)
• Achieving Carbon Neutrality – The Role of Heterogeneous Environmental Regulations on Urban Green Innovation (2022 · Frontiers in Ecology and Evolution · 被引 50)
• Prognosis of hepatocellular carcinoma and its association with immune cells using systemic inflammatory response index (2022 · Future Oncology · 被引 30)
• Dual‐threshold effect of resources and governance on the role of regulations in green innovation: Novel insights from a four‐regime panel approach (2024 · Business Strategy and the Environment · 被引 14)
• Transarterial Chemoembolization Combined With PD-1 Inhibitors Plus Lenvatinib Showed Improved Efficacy for Treatment of Unresectable Hepatocellular Carcinoma Compared With PD-1 Inhibitors Plus Lenvatinib (2023 · Technology in Cancer Research & Treatment · 被引 14)
• Molecular typing and mutational characterization of rectal neuroendocrine neoplasms (2023 · Cancer Medicine · 被引 12)